ABSTRACT
Desmosomes are dynamic complex protein structures involved in cellular adhesion. Disruption of these structures by loss-of-function variants in desmosomal genes leads to a variety of skin- and heart-related phenotypes. In this study, we report TUFT1 as a desmosome-associated protein, implicated in epidermal integrity. In two siblings with mild skin fragility, woolly hair, and mild palmoplantar keratoderma but without a cardiac phenotype, we identified a homozygous splice-site variant in the TUFT1 gene, leading to aberrant mRNA splicing and loss of TUFT1 protein. Patients' skin and keratinocytes showed acantholysis, perinuclear retraction of intermediate filaments, and reduced mechanical stress resistance. Immunolabeling and transfection studies showed that TUFT1 is positioned within the desmosome and that its location is dependent on the presence of the desmoplakin carboxy-terminal tail. A Tuft1-knockout mouse model mimicked the patients' phenotypes. Altogether, this study reveals TUFT1 as a desmosome-associated protein, whose absence causes skin fragility, woolly hair, and palmoplantar keratoderma.
Subject(s)
Hair Diseases , Keratoderma, Palmoplantar , Skin Abnormalities , Animals , Humans , Mice , Desmoplakins/genetics , Desmoplakins/metabolism , Desmosomes/metabolism , Hair/metabolism , Hair Diseases/genetics , Hair Diseases/metabolism , Keratoderma, Palmoplantar/genetics , Keratoderma, Palmoplantar/metabolism , Skin/metabolism , Skin Abnormalities/metabolismABSTRACT
Hair shafts from three trichothiodystrophy (TTD) patients with mutations in the ERCC2 (XPD) gene were examined by transmission electron microscopy. TTD is a rare, recessive disorder with mutations in several genes in the DNA repair/transcription pathway, including ERCC2. Unlike previous studies, the hair shafts were examined after relaxation of their structure by partial disulphide bond reduction in the presence of sodium dodecyl sulphate, permitting improved visualization. Compared with hair shafts of normal phenotype, TTD cuticle cells displayed aberrant marginal bands and exocuticle layers. Clusters of cells stained differently (light versus dark) in the cortex of aberrant shafts, and the keratin macrofibrils appeared much shorter in the cytoplasm. Considerable heterogeneity in these properties was evident among samples and even along the length of single hair shafts. The results are consistent with not only a paucity of high sulphur components, such as keratin-associated proteins, but also a profound imbalance in protein content and organization.
Subject(s)
Hair Diseases , Trichothiodystrophy Syndromes , DNA Repair , Hair/metabolism , Hair Diseases/genetics , Hair Diseases/metabolism , Humans , Trichothiodystrophy Syndromes/genetics , Trichothiodystrophy Syndromes/metabolism , Ultraviolet Rays , Xeroderma Pigmentosum Group D Protein/genetics , Xeroderma Pigmentosum Group D Protein/metabolismABSTRACT
An 80-year-old female presented with a slowly growing 2-cm nodule on her shoulder over a 1-year period. Histopathologic sections of a biopsy specimen showed a multinodular, dermal-based basaloid tumor with areas of clear-cell change, stromal induction, as well as significant cytologic atypia and atypical mitotic activity. An initial investigation revealed positive staining of CDX2, a well-known marker of tumors of gastrointestinal origin. The case was referred to our dermatopathology service for consultation to determine if the lesion was in keeping with a cutaneous metastasis. On receipt of the case, an extended immunohistochemical panel was performed including SATB2, which displayed a similar pattern of staining as seen with CDX2. Although pathologists are most familiar with CDX2 and SATB2 as markers of gastrointestinal origin, the recent dermatopathology literature highlights that primary adnexal lesions of the skin also display positivity for CDX2 and can exhibit SATB2 positivity. We share a case of pilomatrix carcinoma with positive expression of nuclear CDX2 and SATB2, adding to the recent literature to (a) increase recognition of this staining pattern in hair follicle tumors, and (b) discuss briefly the shared molecular underpinnings in the tumorigenesis of gastrointestinal tumors and tumors of hair follicle origin that help clarify this underrecognized immunohistochemical pattern.
Subject(s)
CDX2 Transcription Factor/metabolism , Carcinoma, Skin Appendage/metabolism , Hair Diseases/metabolism , Matrix Attachment Region Binding Proteins/metabolism , Skin Neoplasms/metabolism , Transcription Factors/metabolism , Aged, 80 and over , Biomarkers, Tumor/metabolism , Carcinoma, Skin Appendage/pathology , Female , Hair Diseases/pathology , Humans , Skin Neoplasms/pathologyABSTRACT
BACKGROUND: COVID-19 is a pandemic disease worldwide. Although cutaneous manifestations may present in affected patients, there have been limited studies on the cutaneous findings and hair and nail abnormalities after discharge. OBJECTIVE: To establish the cutaneous manifestations, hair and scalp disorders, and nail abnormalities in patients who recovered from COVID-19 infections. METHODS: A retrospective chart review and telephone interviews were conducted to determine the cutaneous manifestations, hair and scalp disorders, and nail abnormalities of patients aged over 18 years who were diagnosed with COVID-19 infections at Siriraj Hospital, Bangkok, Thailand, between January and June 2020. RESULTS: Ninety-three patients with prior COVID-19 infections participated in the study. The COVID-19 severity had been mild for most (71%). Cutaneous manifestations were reported in 8 patients (8.6%), with the common skin conditions being maculopapular rash and urticaria. The onsets of the skin conditions were before admission (1%), during admission (4.3%), and after discharge (3.2%). Increased hair shedding was also reported in 22 patients (23.7%), with a female predominance. Three patients were affected during admission, while the others were affected after discharge. The patients with moderate, severe, and critical COVID-19 infections experienced significantly more hair shedding than those with asymptomatic and mild diseases. Only 2 patients with mild COVID-19 disease reported nail abnormalities (chromonychia and brittle nails). CONCLUSIONS: Cutaneous manifestations, hair disorders, and nail abnormalities can occur in patients with COVID-19 after their discharge from hospital. Patients should therefore be followed up in anticipation of dermatological problems.
Subject(s)
COVID-19 , Hair Diseases , Nail Diseases , Pandemics , SARS-CoV-2/metabolism , Adult , Aged , Aged, 80 and over , COVID-19/epidemiology , COVID-19/metabolism , Female , Follow-Up Studies , Hair/metabolism , Hair/virology , Hair Diseases/epidemiology , Hair Diseases/metabolism , Hair Diseases/virology , Humans , Male , Middle Aged , Nail Diseases/epidemiology , Nail Diseases/metabolism , Nail Diseases/virology , Nails/metabolism , Nails/virology , Skin/metabolism , Skin/virologyABSTRACT
BACKGROUND: The rate of premature greying, referred to as canities, varies among populations, and effective treatments are lacking. However, few studies at the molecular level have been reported. OBJECTIVES: Comparing lipid profiles of individuals with premature canities and healthy volunteers to explore the mechanism of premature canities. METHODS: Ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF-MS) was used to detect lipids in the hair follicle root. Multivariate data analysis was used to show lipid changes in follicle roots. RESULTS: We identified lipids in the hair follicle root that differ between black and white hair and analysed key lipids contributing to white hair development. We divided the samples into three groups: PC-WH (Premature canities-White hair), PC-PH (Premature canities-Pigmented hair), Control-PH (Pigmented hair). Phosphatidylethanolamine (PE), phosphatidylcholine (PC), vitamin D3 (VD3) and cholesterol in Control-PH were higher than those in PC-WH. Sphingomyelin (SP), phosphatidic acid (PA), VD3 and diglyceride (DG) were lower in PC-WH than in PC-PH. Levels of VD3 were highest in Control-PH, gradually decreased as the severity of PC-PH increased and were lowest in PC-WH. CONCLUSION: There are 7 main class candidate compounds involved in the generation of white hair. VD3 showed a substantial decrease in white hair and was a potential target for further studies of premature canities.
Subject(s)
Hair Color , Hair Diseases/metabolism , Hair Follicle/metabolism , Lipids/analysis , Adolescent , Adult , Biomarkers/analysis , Biomarkers/metabolism , Case-Control Studies , Cholecalciferol/metabolism , Cholesterol/metabolism , Chromatography, Liquid/methods , Diglycerides/metabolism , Humans , Mass Spectrometry/methods , Phosphatidic Acids/metabolism , Phosphatidylcholines/metabolism , Phosphatidylethanolamines/metabolism , Sphingomyelins/metabolism , Young AdultABSTRACT
Pilomatricoma usually contains a mutation in CTNNB1 that encodes ß-catenin (BC). It also shows nuclear accumulation of BC protein, which plays an important role in tumorigenesis of pilomatricoma. In vitro studies have indicated that mutant BC protein is unphosphorylated and shows nuclear accumulation, but this theory has not been confirmed in various tumors with CTNNB1 mutation. We examined immunohistochemical localization of phosphorylated BC (pBC) and unphosphorylated BC (npBC) with regard to the modes of cell death or differentiation in 25 cases of pilomatricoma. As for the component showing shadow cell differentiation, BC was detected in cytoplasm/nucleus and along cell membrane in basaloid cells, whereas only in the latter in transitional cells in all cases. Meanwhile, npBC was localized along cell membrane of transitional cells, but not in basaloid cells, nor in nucleus of any components. The components with squamous differentiation also revealed the staining patterns similar to those seen in shadow cell differentiation in some cases. pBC was found in some cell fragments in the amorphous debris containing apoptotic bodies among shadow cell nests. These results suggested that npBC plays an important role in cell adhesion during differentiation and that pBC expression is associated with apoptosis of basaloid cells in pilomatricoma. BC accumulated in the nucleus was not immunoreactive for npBC possibly due to post-translational modification or conformational changes that resulted in loss of or masked antigenicity when BC is assumed to be unphosphorylated.
Subject(s)
Hair Diseases/pathology , Pilomatrixoma/pathology , Skin Neoplasms/pathology , beta Catenin/metabolism , Biomarkers, Tumor/metabolism , Cell Death/physiology , Cell Differentiation/physiology , Epithelial Cells/metabolism , Epithelial Cells/pathology , Hair Diseases/metabolism , Humans , Immunohistochemistry , Phosphorylation , Pilomatrixoma/metabolism , Skin Neoplasms/metabolismABSTRACT
The relationship between the geometric and mechanical profiles of hair fibers has been studied, with special focus on curly samples. Incidental observations pointed to a significantly different viscoelastic character with varying curliness. Further investigations confirmed initial observations, showing an initial distinct toe region behavior for curly fibers on the stress-strain plot, which is absent for straight fibers. This behavior suggested a difference in the viscoelastic nature of the curly fiber that is linked to mechanical energy stored in the fiber. Results also suggest that the strength of hair depends on two main components, and further pointed out that de facto methods of tensile testing may erode curly fiber strength during preparation. The main outcome of this study is that the tensile strength (σT) of hair fibers is composed of two (rather than one main) components, namely the toe region (σt) and the elastic region (σε), so that: σT=σt+σε. For noncurly fibers, the greatest part of fiber strength is derived from σε, while σt ≈ 0. For curly fibers, σt (i.e., springiness) adds significantly to the overall strength, even though σε remains the major contributor. Although these results require validation in larger studies, they are significant in the current understanding of curly hair. Also, they may represent a fundamental shift from the current understanding of tensile testing of human hair in general.
Subject(s)
Hair Diseases/metabolism , Hair/physiology , Tensile Strength/physiology , Biomechanical Phenomena , Elasticity , Hair Diseases/pathology , Humans , Models, TheoreticalABSTRACT
Perforating pilomatricoma (PP) is a rare clinical variant of pilomatricoma presenting as a crusted or ulcerated nodule. Previous reports have suggested that the tumor cells perforate the epidermis through a process of transepithelial elimination. Here, we report six cases of PP and examine the mechanism of transepithelial elimination in PP. Histologically, the dermis above or around the tumor nest exhibited edema, dilated vascular spaces, sparse collagen bundles and absence of elastic fibers, suggesting anetodermic changes in all cases. Immunohistochemistry demonstrated many CD68-positive macrophages around the tumor nests. Matrix metallopeptidase (MMP)-9 and MMP-12 were expressed in the inflammatory cells and tumor cells, and were also present in the epidermis and fibroblasts in all cases. We speculate that in PP anetodermic change caused by MMP and elastases including MMP-9 and MMP-12 may precede elimination of the tumor.
Subject(s)
Dermis , Hair Diseases/metabolism , Matrix Metalloproteinase 12/biosynthesis , Matrix Metalloproteinase 9/biosynthesis , Pilomatrixoma/metabolism , Skin Neoplasms/metabolism , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Child , Dermis/metabolism , Dermis/pathology , Elastic Tissue/pathology , Epidermis/metabolism , Epidermis/pathology , Hair Diseases/pathology , Humans , Immunohistochemistry , Macrophages/metabolism , Male , Pilomatrixoma/pathology , Skin Neoplasms/pathology , Skin Ulcer/metabolism , Skin Ulcer/pathologyABSTRACT
It is an indisputable fact that obesity is associated with a series of health problems. One important hallmark of obesity is excessive accumulation of lipids in the adipocyte, especially triglyceride (TG). Currently, the adipocyte has been considered not only as a huge repository of excess energy in the form of fat but also as an important source of multiple hormones and cytokines called adipokines. In obesity, the adipocyte is dysfunctional with excessive production and secretion of pro-inflammatory adipokines, such as tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), and leptin. On the other hand, accumulating evidence has shown that leptin plays a vital role in stimulating angiogenesis, controlling lipid metabolism, and modulating the production of pro-inflammatory cytokines. Furthermore, the various activities of leptin are related to the wide distribution of leptin receptors. Notably, it has been reported that enhanced leptin levels and dysfunction of the leptin signaling pathway can influence diverse skin diseases. Recently, several studies revealed the roles of leptin in wound healing, the hair cycle, and the pathogenic development of skin diseases, such as psoriasis, lupus erythematosus, and dermatological cancers. However, the exact mechanisms of leptin in modulating the dermatological diseases are still under investigation. Therefore, in the present review, we summarized the regulatory roles of leptin in the pathological progression of diverse diseases of skin and skin appendages. Furthermore, we also provided evidence to elucidate the complicated relationship between leptin and different dermatological diseases, such as systemic lupus erythematosus (SLE), psoriasis, hidradenitis suppurativa, and some skin tumors.
Subject(s)
Disease Susceptibility , Leptin/genetics , Leptin/metabolism , Skin Diseases/etiology , Skin Diseases/metabolism , Animals , Biomarkers , Energy Metabolism , Gene Expression Regulation , Hair/metabolism , Hair Diseases/etiology , Hair Diseases/metabolism , Hair Diseases/pathology , Humans , Obesity/complications , Obesity/etiology , Obesity/metabolism , Organ Specificity , Reactive Oxygen Species/metabolism , Skin Diseases/pathologyABSTRACT
INTRODUCTION: Benign cutaneous tumors with follicular differentiation are alleged to differentiate toward parts of the hair follicle. Connexin 43 (Cx43) is a gap junction protein, the tumoral role of which has been investigated in several types of tumors. OBJECTIVE: To study the pattern of expression of Cx43 in benign cutaneous tumors with follicular differentiation and to compare it with that shown by their alleged anatomical counterparts of the hair follicle. MATERIALS AND METHODS: Five cases each of trichofolliculoma, trichilemmoma, fibrofolliculoma/trichodiscoma, trichoblastoma, trichoepithelioma, pilomatrixoma, and proliferating trichilemmal tumor, 3 cases of pilar sheath acanthoma, and 1 case of tumor of the follicular infundibulum were examined. Anti-Cx43 antibody was used. RESULTS: Cx43 was expressed by all follicular tumors studied. Comparisons between trichoblastoma and trichoepithelioma and their respective normal counterparts could not be made. In 3 tumors (trichofolliculoma, pilomatrixoma, and the spectrum fibrofolliculoma/trichodiscoma), there was a parallelism between their Cx43 expression pattern and that of their alleged anatomical counterparts. In pilar sheath acanthoma, trichilemmoma, and the tumor of the follicular infundibulum, we only found partial similarities in Cx43 expression. Only the proliferating trichilemmal tumor showed a discordant pattern of expression. CONCLUSIONS: Cx43 expression is preserved in benign cutaneous tumors with follicular differentiation and the patterns of Cx43 expression in benign cutaneous tumors with follicular differentiation parallel those of their alleged anatomical counterparts in 5 types (either totally or partially). This preservation might be related to the good behavior of the entities studied.
Subject(s)
Connexin 43/biosynthesis , Hair Diseases/metabolism , Hair Follicle/pathology , Skin Neoplasms/metabolism , Connexin 43/analysis , Hair Diseases/pathology , Hair Follicle/metabolism , Humans , Skin Neoplasms/pathologyABSTRACT
Matrical carcinoma with melanocytic hyperplasia (MCMH), previously referred to as malignant melanocytic matricoma, is a rare variant of the uncommon pilomatrical carcinoma, occurring most often on the head/neck and upper backs of middle-aged men. Nodular lesions may resemble pigmented basal cell carcinoma or melanoma clinically. We present a case of MCMH in a Hispanic patient with history of melanoma. Histopathological clues to appropriate diagnosis include basaloid cells, numerous atypical mitotic figures, matrical differentiation, shadow cells, strong diffuse nuclear and cytoplasmic expression of ß-catenin, and interspersed pigmented dendritic melanocytes.
Subject(s)
Carcinoma, Basal Cell , Carcinoma, Skin Appendage , Hair Diseases , Melanocytes , Melanoma , Skin Neoplasms , Aged, 80 and over , Carcinoma, Basal Cell/diagnosis , Carcinoma, Basal Cell/metabolism , Carcinoma, Basal Cell/pathology , Carcinoma, Skin Appendage/diagnosis , Carcinoma, Skin Appendage/metabolism , Carcinoma, Skin Appendage/pathology , Diagnosis, Differential , Hair Diseases/diagnostic imaging , Hair Diseases/metabolism , Hair Diseases/pathology , Humans , Male , Melanocytes/metabolism , Melanocytes/pathology , Melanoma/diagnosis , Melanoma/metabolism , Melanoma/pathology , Mexico , Skin Neoplasms/diagnosis , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Melanoma, Cutaneous MalignantABSTRACT
BACKGROUND: The role of the mammalian target of rapamycin (mTOR) in hair follicle tumorigenesis is unclear. mTOR controls cell growth and can be activated through ribosomal S6 kinase. Herein, we sought to evaluate the expression of phospho-S6 in six different benign and malignant follicular tumor types. METHODS: 76 cases were selected (17 fibrofolliculomas, 20 trichoepitheliomas, 10 tricholemmomas, 19 pilomatricomas, 1 malignant proliferating tricholemmal tumor, 8 tricholemmal carcinomas, and 1 trichoblastic carcinoma) and collected over 16 years. Immunohistochemistry with monoclonal antibody for phospho-S6 was performed and analyzed semi-quantitatively; statistical analysis using the χ2 test was performed, with P < 0.05 considered significant. RESULTS: All malignant neoplasms in our series (8/8 [100%] cases of tricholemmal carcinoma, 1/1 [100%] trichoblastic carcinoma, and 1/1 [100%] malignant proliferating tricholemmal tumor) showed a strong and diffuse pattern of staining for phospho-S6 involving 70% to 90% of tumor cells. By contrast, a minority of benign tumors were positive for phospho-S6 and most stained in a patchy pattern including 12/17 (71%) fibrofolliculomas, 9/20 (45%) trichoepitheliomas and 1/10 (10%) tricholemmomas, involving 30% to 50%, 5% to 20%, and 40% to 50% of tumor cells, respectively. Most pilomatricomas (17/19 [89%]) exhibited a stronger, but distinctive staining pattern, staining mostly the basaloid cells with a multifocal distribution, involving 70% to 90% of tumor cells. CONCLUSIONS: Phospho-S6 is differentially expressed among benign and malignant hair follicle tumors (P = 0.0044). While malignant tumors show diffuse expression, only a small subset of benign neoplasms were positive, primarily in a patchy distribution.
Subject(s)
Biomarkers, Tumor/analysis , Hair Diseases/diagnosis , Hair Follicle/pathology , Ribosomal Protein S6 Kinases/analysis , Skin Neoplasms/diagnosis , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Female , Hair Diseases/metabolism , Hair Diseases/pathology , Hair Follicle/metabolism , Humans , Infant , Male , Middle Aged , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , TOR Serine-Threonine Kinases/metabolism , Young AdultSubject(s)
Hair Diseases/pathology , Hair Follicle/pathology , Skin Neoplasms/pathology , Stromal Cells/pathology , Biomarkers, Tumor/analysis , Diagnosis, Differential , Female , Hair Diseases/metabolism , Hair Follicle/chemistry , Humans , Immunohistochemistry , Middle Aged , Skin Neoplasms/chemistry , Stromal Cells/chemistryABSTRACT
BACKGROUND: Pilomatricoma is a relatively common benign cutaneous adnexal neoplasm with differentiation towards the hair matrix, inner sheath of hair follicle and hair cortex. Proliferating pilomatricoma is a rare variant of pilomatricoma that can rapidly increase and may be misidentified as a malignant tumor. We herein report the cytopathological findings of proliferating pilomatricoma misdiagnosed as a malignant parotid tumor. CASE PRESENTATION: A 64-year-old man noticed an acne-like nodule in the left parotid region. It was painless, but it increased to a maximum diameter of 4.5 cm over 2 years. Clinically, left parotid gland carcinoma was suspected, and fine-needle aspiration cytology was performed. Clusters of epithelial cells were observed in a necrotic background, and malignant epithelial cells derived from salivary glands were suspected. Histologically, the resected tumor was diagnosed as proliferating pilomatricoma composed of basophilic cells and shadow cells apart from the parotid gland. However, on a re-evaluation of the cytological specimens, the irregular-shaped epithelial cells were considered to be from basophilic cells. Shadow cells with nuclear disappearance were also confirmed. Tumor recurrence and metastasis have not been observed in the four years since surgery. CONCLUSION: The present case was first interpreted as a malignant parotid gland tumor, but it was actually a benign skin appendage tumor. Pilomatricoma sometimes rapidly increases and may be mistaken for a malignant tumor. Although it is critical to recognize not only basophilic cells but also shadow cells, it cannot be diagnosed by cytological findings. The final diagnosis should be made on excision specimen only.
Subject(s)
Cell Proliferation , Diagnostic Errors , Hair Diseases/pathology , Parotid Neoplasms/pathology , Pilomatrixoma/pathology , Skin Neoplasms/pathology , Biopsy, Fine-Needle , Hair Diseases/metabolism , Hair Diseases/surgery , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Parotid Neoplasms/chemistry , Pilomatrixoma/chemistry , Pilomatrixoma/surgery , Predictive Value of Tests , Skin Neoplasms/chemistry , Skin Neoplasms/surgeryABSTRACT
In murine skin, dermal white adipose tissue (DWAT) undergoes major changes in thickness in synchrony with the hair cycle (HC); however, the underlying mechanisms remain unclear. We sought to elucidate whether increased DWAT thickness during anagen is mediated by adipocyte hypertrophy or adipogenesis, and whether lipolysis or apoptosis can explain the decreased DWAT thickness during catagen. In addition, we compared HC-associated DWAT changes between spontaneous and depilation-induced hair follicle (HF) cycling to distinguish between spontaneous and HF trauma-induced events. We show that HC-dependent DWAT remodelling is not an artefact caused by fluctuations in HF down-growth, and that dermal adipocyte (DA) proliferation and hypertrophy are HC-dependent, while classical DA apoptosis is absent. However, none of these changes plausibly accounts for HC-dependent oscillations in DWAT thickness. Contrary to previous studies, in vivo BODIPY uptake suggests that increased DWAT thickness during anagen occurs via hypertrophy rather than hyperplasia. From immunohistomorphometry, DWAT thickness likely undergoes thinning during catagen by lipolysis. Hence, we postulate that progressive, lipogenesis-driven DA hypertrophy followed by dynamic switches between lipogenesis and lipolysis underlie DWAT fluctuations in the spontaneous HC, and dismiss apoptosis as a mechanism of DWAT reduction. Moreover, the depilation-induced HC displays increased DWAT thickness, area, and DA number, but decreased DA volume/area compared to the spontaneous HC. Thus, DWAT shows additional, novel HF wounding-related responses during the induced HC. This systematic reappraisal provides important pointers for subsequent functional and mechanistic studies, and introduces the depilation-induced murine HC as a model for dissecting HF-DWAT interactions under conditions of wounding/stress.
Subject(s)
Adipose Tissue, White/pathology , Dermis/pathology , Hair Diseases/metabolism , Hair Follicle/pathology , Hair/physiology , Adipose Tissue, White/metabolism , Animals , Apoptosis , Cell Proliferation , Cells, Cultured , Disease Models, Animal , Female , Hair Diseases/pathology , Hair Removal , Humans , Hyperplasia , Hypertrophy , Mice , Mice, Inbred C57BL , PeriodicityABSTRACT
Pilomatrix (pilomatrical) carcinoma is a rare cutaneous adnexal tumor with matrical differentiation and recurrent and metastatic potential. Sarcomatoid pilomatrix carcinoma is a rare variant which shows a sarcomatoid component intermingling with the epithelial one. There are only 4 cases previously published. We present an additional case on the hand of a 78 year-old man which appeared as a 6 mm hyperkeratotic, focally ulcerated plaque. A shave biopsy demonstrated a dermal infiltrative neoplasm, composed of markedly atypical-appearing basaloid cells with focal necrotic/ghost cells, as well as an intimately associated population of atypical oval to spindle-shaped cells. Both the epithelial and the sarcomatoid components expressed cytokeratins (CKs) AE1/AE3, CK 5/6 and CAM 5.2, as well as beta-catenin and LEF-1. The tumor failed to express CK7, CK20, S100, thyroid transcription factor 1 (TTF1), CDX2, prostate-specific antigen (PSA) and CD34. The tumor was completely excised with Mohs surgery, and there has been no recurrence in the 8 months of follow-up to date.
Subject(s)
Hair Diseases , Neoplasm Proteins/metabolism , Pilomatrixoma , Skin Neoplasms , Aged , Hair Diseases/metabolism , Hair Diseases/pathology , Hair Diseases/surgery , Humans , Male , Pilomatrixoma/metabolism , Pilomatrixoma/pathology , Pilomatrixoma/surgery , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Skin Neoplasms/surgeryABSTRACT
In a previous study, we showed that microRNA-675 (miR-675) was significantly down-regulated in patients with tricho-dento-osseous (TDO) syndrome. One of the main features of TDO syndrome is dentin hypoplasia. Thus, we hypothesize that miR-675 plays a role in dentin development. In this study, we determined the role of miR-675 in the odontogenic differentiation of human dental pulp cells (hDPCs). Stable overexpression and knockdown of miR-675 in hDPCs were performed using recombinant lentiviruses containing U6 promoter-driven miR-675 and short hairpin-miR675 expression cassettes, respectively. Alkaline phosphatase (ALP) assay, Alizarin red staining assay, quantitative polymerase chain reaction (qPCR), Western blot analysis, and immunofluorescent staining revealed the promotive effects of miR-675 on the odontogenic differentiation of hDPCs. Further, we found that miR-675 facilitates the odontogenic differentiation process of hDPCs by epigenetic regulation of distal-less homeobox (DLX3). Thus, for the first time, we determined that miR-675 regulates the odontogenic differentiation of hDPCs by inhibiting the DNA methyltransferase 3 beta (DNMT3B)-mediated methylation of DLX3. Our findings uncover an unanticipated regulatory role for miR-675 in the odontogenic differentiation of hDPCs by epigenetic changes in DLX3 and provide novel insight into dentin hypoplasia feature in TDO patients.
Subject(s)
Cell Differentiation/genetics , Craniofacial Abnormalities/genetics , Dental Enamel Hypoplasia/genetics , Dental Pulp/cytology , Epigenesis, Genetic/genetics , Hair Diseases/genetics , Homeodomain Proteins/metabolism , MicroRNAs/metabolism , Transcription Factors/metabolism , Craniofacial Abnormalities/metabolism , Craniofacial Abnormalities/pathology , DNA (Cytosine-5-)-Methyltransferases/genetics , DNA (Cytosine-5-)-Methyltransferases/metabolism , Dental Enamel Hypoplasia/metabolism , Dental Enamel Hypoplasia/pathology , Dental Pulp/metabolism , Dentin/metabolism , Dentin/pathology , Gene Knockdown Techniques , Hair Diseases/metabolism , Hair Diseases/pathology , Homeodomain Proteins/genetics , Humans , MicroRNAs/genetics , Primary Cell Culture , Transcription Factors/genetics , DNA Methyltransferase 3BABSTRACT
Prostanoids, including prostaglandins (PGs) and thromboxane A2 (TXA2), are a family of lipid-derived autacoids that modulate many physiological systems and pathological contexts. Prostanoids are generated by sequential metabolism of arachidonic acid, catalysed by cyclo-oxygenase, to PGH2, which is then converted to PGD2, PGE2, PGF2α, PGI2 and TXA2, catalysed by their specific synthases. Recent evidence suggests that prostanoids play a role in regulating hair growth. The PGF2α analogue is Food and Drug Administration-approved in the US and routinely used to enhance the growth of human eyelashes. PGE2 is reported to protect from radiation-induced hair loss in mice. Conversely, PGD2 inhibits hair growth. This paper reviews the metabolism of prostanoids and the expression pattern of prostanoid receptors in hair follicles, focussing on their different and opposing effects on hair growth and the underlying mechanisms. This has potential clinical relevance in the treatment and prevention of hair disorders.
Subject(s)
Hair Diseases/metabolism , Hair Follicle/metabolism , Prostaglandins/metabolism , Regeneration , Animals , Hair Diseases/drug therapy , Hair Diseases/physiopathology , Hair Follicle/drug effects , Hair Follicle/growth & development , Humans , Receptors, Prostaglandin/metabolism , Regeneration/drug effects , Signal TransductionABSTRACT
Because children diagnosed with WNT-activated medulloblastoma have a 10-year overall survival rate of 95%, active long-term follow-up is critically important in reducing mortality from other causes. Here, we describe an 11-year-old adopted female who developed multiple pilomatrixomas 3 years after diagnosis of WNT-activated medulloblastoma, an unusual finding that prompted deeper clinical investigation. A heterozygous germline APC gene mutation was discovered, consistent with familial adenomatous polyposis. Screening endoscopy revealed numerous precancerous polyps that were excised. This case highlights the importance of long-term follow-up of pediatric cancer survivors, including attention to unexpected symptoms, which might unveil an underlying cancer predisposition syndrome.